保健三角公司正在通过重要的人工智能采购和产品推出,向数字保健创新者转变,提高投资者的信心及其存量。 Healthcare Triangle Inc. is transforming into a digital health innovator through key AI acquisitions and product launches, boosting investor confidence and its stock.

医疗保健三角公司(HCTI)正在进行大胆的变革,推行包括Teyame.AI在内的收购。 Teyame.AI是一个欧洲大赦国际客户参与平台,预计将在2025年产生3 400万美元收入,并推进与Niyama和Ezovion的交易,以扩大其数字保健平台。 Healthcare Triangle Inc. (HCTI) is executing a bold transformation, pursuing acquisitions including Teyame.AI, a European AI customer engagement platform expected to generate $34 million in revenue in 2025, and advancing deals with Niyama and Ezovion to expand its digital health platform. 该公司启动了QuantumNexis,这是AI SaaS统一保健数据的一个基因化工具,并完成了授权重组,以获得资本,尽量减少稀释。 The company launched QuantumNexis, a generative AI SaaS tool for unifying healthcare data, and completed a warrant restructuring to secure capital with minimal dilution. 在HITRIT认证和现有客户信任的支持下,HCTI正在从一个以合规为重点的信息技术供应商转向一个前端数字保健创新者。 Backed by HITRUST certification and existing client trust, HCTI is shifting from a compliance-focused IT provider to a front-end digital health innovator. 其股票自2025年9月以来上涨了31%以上,反映出市场对其战略增长举措的信心。 Its stock rose over 31% since September 2025, reflecting market confidence in its strategic growth moves.